RNWAX
Price
$98.43
Change
+$0.49 (+0.50%)
Updated
Jul 27 closing price
Net Assets
90.71B
SEKAX
Price
$27.23
Change
-$0.74 (-2.65%)
Updated
Jul 24 closing price
Net Assets
73.51M
Interact to see
Advertisement

RNWAX vs SEKAX

RNWAX vs SEKAX Comparison Chart in %
View a ticker or compare two or three
VS
RNWAX vs. SEKAX commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWAX is a Buy and SEKAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 90.7B vs. SEKAX (73.5M). SEKAX pays higher dividends than RNWAX: SEKAX (2.08) vs RNWAX (0.49). RNWAX was incepted earlier than SEKAX: RNWAX (24 years) vs SEKAX (25 years). SEKAX (1.72) and RNWAX (1.66) have similar cost to investors . SEKAX is a more actively managed with annual turnover of: 94.00 vs. RNWAX (46.00). RNWAX has a lower initial minimum investment than SEKAX: RNWAX (250) vs SEKAX (1000). SEKAX annual gain was more profitable for investors over the last year : 33.89 vs. RNWAX (15.42). SEKAX return over 5 years is better than : 27.84 vs. RNWAX (10.18).
RNWAXSEKAXRNWAX / SEKAX
Total Expense Ratio1.661.15144%
Annual Report Gross Expense Ratio1.661.7297%
Fund Existence24 years25 years-
Gain YTD10.89520.22154%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets90.7B73.5M123,401%
Annual Yield % from dividends0.492.0823%
Returns for 1 year15.4233.8946%
Returns for 3 years35.9664.1056%
Returns for 5 years10.1827.8437%
Returns for 10 years93.07107.2387%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIIIX17.64N/A
N/A
Principal Diversified Intl Inst
RRFDX44.37N/A
N/A
T. Rowe Price Equity Income R
TEMWX18.33N/A
N/A
Templeton World A
HISFX17.60N/A
N/A
Hennessy Small Cap Financial Instl
PPADX23.40N/A
N/A
GMO U.S. Opportunistic Value III